|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| NET REVENUES | |||||
| OPERATING EXPENSES | |||||
| Cost of sales (exclusive of amortization of acquired intangible assets) | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Amortization of acquired intangible assets | |||||
| Change in fair value of contingent consideration | |||||
| Total operating expenses, net | |||||
| Operating (loss) income | |||||
| Interest income | |||||
| Changes in fair value of trading securities | |||||
| Net gains on equity securities | |||||
| Interest expense | |||||
| Other income | |||||
| (Loss) income before income taxes | |||||
| Income tax (benefit) expense | |||||
| Net (loss) income | |||||
| Comprehensive loss | |||||
| (Loss) earnings per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...